Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

By Manuja Anju   Manuja Balvinder K.   Kaushik Jyoti   Singha Harisankar   Singh Raj Kumar  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 5, 2013-10 ,pp. : 535-544

Informa Healthcare

Access to resources Recommend Favorite

CpG oligodeoxynucleotides: postexposure prophylaxis for prion diseases?

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

CpG Oligodeoxynucleotides: A Novel Therapeutic Approach For Atopic Disorders

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 3, 2003-09 ,pp. : 199-205

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of 1-methyl-1-nitrosourea-induced mammary tumours with immunostimulatory CpG motifs and 13-cis retinoic acid in female rats: histopathological study

By Liska Jan   Macejova Danica   Galbavy Stefan   Baranova Maria   Zlatos Jozef   Stvrtina Svetoslav   Mostbock Sven   Weiss Richard   Scheiblhofer Sandra   Thalhamer Joseph   Brtko Julius  

Experimental and Toxicologic Pathology, Vol. 55, Iss. 2-3, 2003-09 ,pp. : 173-179

Urban & Fischer

Access to resources Recommend Favorite

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

By Gupta Kaveri  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 137-145

Adis International

Access to resources Recommend Favorite